PAHO/WHO/MPP Deal History & Licensing Activity
PAHO/WHO/MPP is a life sciences. Over the past three years, PAHO/WHO/MPP has been involved in 2 licensing and acquisition transactions, with a primary focus on mRNA (4 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
mRNA
Focus Area
Infectious Disease
PAHO/WHO/MPP Recent Deal Activity
Licensing, acquisition, and partnership transactions involving PAHO/WHO/MPP in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| mRNA influenza A(H5N1) vaccine | Sinergium Biotech | mRNA | Preclinical | collaboration | Jun 2025 |
| mRNA H5N1 influenza vaccine | Sinergium Biotech | mRNA | Preclinical | collaboration | Jun 2025 |
PAHO/WHO/MPP Pipeline Focus
Therapeutic areas and modalities where PAHO/WHO/MPP is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches PAHO/WHO/MPP's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
mRNA Benchmarks
Upfront, milestone, and royalty benchmarks for mrna deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About PAHO/WHO/MPP Licensing & Deal Activity
PAHO/WHO/MPP is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, PAHO/WHO/MPP ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for PAHO/WHO/MPP include Infectious Disease (4 deals and trials). In terms of modality, PAHO/WHO/MPP has shown particular interest in mrna.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for PAHO/WHO/MPP and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against PAHO/WHO/MPP's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.